Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Alcresta Infused With $10M Series B To Get First Product To Market

This article was originally published in The Pink Sheet Daily

Executive Summary

The Massachusetts nutritionals company has guaranteed it can transition from a development company to a commercial company without the help of a partner due to a recent infusion of cash but hopes to strike partnerships for certain indications and regions once the product gets to market.


Related Content

Financings Of The Fortnight Looks For A Strong IPO Year To Pick Up Further In Second Half
Alcresta Launches With Dynamic Business Model; Raises $10M Series A
Alnara Execs Start Anew With Allena; $15 M Series A
Lilly To Buy Alnara And Its Non-Porcine Pancreatic Enzyme Replacement Therapy


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts